Refine
Has Fulltext
- yes (19)
Is part of the Bibliography
- yes (19)
Year of publication
Document Type
- Journal article (19)
Language
- English (19)
Keywords
- Tanzania (5)
- meningococcal disease (3)
- Germany (2)
- HBMEC (2)
- Haemophilus influenzae (2)
- MRSA (2)
- Meningitis (2)
- Neisseria meningitidis (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- men who have sex with men (2)
- meningitis (2)
- neuroinflammation (2)
- surgical site infection (2)
- Apoptosis (1)
- B neisseria meningitidis (1)
- C-reactive protein (1)
- Caspase (1)
- DNA recombination (1)
- ESBL (1)
- Elderly (1)
- Enterobacteriaceae (1)
- Geriatric care (1)
- Geriatrics (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Neisseria gonorrhoeae (1)
- Neuroinflammation (1)
- Nursing homes (1)
- P. aeruginosa (1)
- Pathogens (1)
- S. aureus (1)
- ST1797 (1)
- ST88 (1)
- Staphylococcus aureus (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- agar (1)
- antigen (1)
- antimicrobial resistance (1)
- atypical chemokine receptor 3 (1)
- aureus infections (1)
- bacterial meningitis (1)
- bactericidal activity (1)
- biosynthesis (1)
- blood–brain barrier (1)
- brain barrier (1)
- central-nervous-system (1)
- cephalosporin-resistant gram-negative bacteria (1)
- chemical properties (1)
- children (1)
- chorioamnionitis (1)
- choroid-plexus (1)
- colonization (1)
- comparative genomics (1)
- cord blood (1)
- differential age distribution (1)
- disease-associated (1)
- elucidation (1)
- epithelial cells (1)
- factor H (1)
- field gel-electrophoreresis (1)
- gene conversion (1)
- gene expression (1)
- generalized anxiety disorder (1)
- genetics (1)
- genome sequencing (1)
- genomic databases (1)
- group-B (1)
- haemophilus influenzae (1)
- homologous recombination (1)
- human brain microvascular endothelial cells (1)
- immunology (1)
- immunomodulation (1)
- in vitro (1)
- infection (1)
- inflammation (1)
- invasive meningococcal disease (1)
- mammalian genomics (1)
- meningococcal lineages (1)
- meningococcal polysaccharides (1)
- microbiology (1)
- microvascular endothelial-cells (1)
- molecular epidemiology (1)
- monocytes (1)
- mouse models (1)
- neisseria meningitidis (1)
- neonatal morbidity (1)
- nitrites (1)
- nuclear magnetic resonance (1)
- outer membrane protein (1)
- panton-valentine leukocidin (1)
- phase variation (1)
- piperacillin (1)
- piperacillin/tazobactam (1)
- plexus epithelial-cells (1)
- population genetics (1)
- recombinant proteins (1)
- serogroup B (1)
- serogroup-Y (1)
- strain MC58 (1)
- structural determination (1)
- tazobactam (1)
- tight junctions (1)
- vaccine development (1)
- water microbiology (1)
Institute
EU-Project number / Contract (GA) number
- 278864 (1)
Background
Haemophilus influenzae (Hi) is a Gram-negative bacterium that may cause sepsis or meningitis, treatment of which mainly includes β-lactam antibiotics. Since 2019 EUCAST breakpoints for piperacillin/tazobactam have been available. Little is known about the prevalence and mechanisms of piperacillin/tazobactam resistance in Hi.
Objectives
To provide reliable prevalence data for piperacillin/tazobactam resistance in Hi in Germany, to evaluate different antibiotic susceptibility testing methods and to examine possible resistance mechanisms.
Methods
According to EUCAST breakpoints, the MIC for piperacillin/tazobactam resistance is >0.25 mg/L. All invasive Hi in Germany from 2019 were examined by gradient agar diffusion (GAD) for piperacillin/tazobactam susceptibility. Piperacillin/tazobactam broth microdilution (BMD), piperacillin GAD on tazobactam-containing agar [piperacillin GAD on Mueller–Hinton agar with horse blood (MH-F)/tazobactam) and piperacillin/tazobactam agar dilution (AD) were used for confirmation. Phenotypic testing was complemented by ftsI sequencing.
Results
Piperacillin/tazobactam GAD resulted in 2.9% (21/726) resistant Hi. BMD did not confirm piperacillin/tazobactam resistance. Two strains were found resistant by AD, of which one was also resistant using piperacillin GAD on MH-F/tazobactam. Overall, we found two strains with a piperacillin/tazobactam MIC >0.25 mg/L in at least two different tests (0.3%). Both were β-lactamase-producing amoxicillin/clavulanate-resistant with PBP3 mutations characterized as group III-like+. Relevant PBP3 mutations occurred in six strains without phenotypic piperacillin/tazobactam resistance. These mutations suggest a reduced efficacy of β-lactam antibiotics in these isolates.
Conclusions
Piperacillin/tazobactam resistance prevalence in invasive Hi is low in Germany. Reduced susceptibility was correlated with PBP3 mutations, in particular with group III mutations.